The US Justice Department’s (DOJ) Antitrust Division on Monday, September 17, gave its approval to the US$52 billion deal merging Express Scripts with Cigna.
Shareholders voted to approve the merger last month, despite early opposition from activist investor Carl Icahn, who wrote an open letter urging shareholders to reject the deal.He later changed his opinion on the merger. The Justice Department antitrust division said it looked at Cigna’s current PBM services provider, OptumRx, which is owned by UnitedHealth Group. ”
The DOJ Antitrust Division stated it looked at Cigna’s current pharmacy benefit manager (PBM) services provider, OptumRx, which is owned by UnitedHealth Group. “The (DOJ antitrust) Division understands that Cigna intends to use (Express Scripts) for PBM services and that Cigna’s current PBM services provider, UnitedHealthcare’s subsidiary Optum, will be free to compete for PBM customers that purchase medical insurance from Cigna upon closing of the transaction,” The Justice Department announced in a statement Monday.
Featured News
EU’s Largest Economies Push to Reduce Reliance on Foreign Payment Systems
Mar 12, 2026 by
CPI
Warren Presses Amazon for Answers on Pricing Practices for Government Buyers
Mar 12, 2026 by
CPI
EU Antitrust Chief Raises Concerns Over Big Tech Control of AI
Mar 12, 2026 by
CPI
Burson Adds Senior Advisor to Strengthen Competition Team
Mar 12, 2026 by
CPI
South Korea Fines Pork Processors for Price-Fixing in Retail Supply Deals
Mar 12, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece